SMTL ID : 2weh.1

Thermodynamic Optimisation of Carbonic Anhydrase Fragment Inhibitors

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.09 Å

Oligo State

monomer

Ligands

1 x ZN: ZINC ION(Non-covalent)

ZN.1: 4 residues within 4Å: Chain A: H.93, H.95, H.118 Ligands: FB1.2 3 PLIP interactions: 3 interactions with chain A Metal complexes: A:H.93, A:H.95, A:H.118

1 x FB1: 2-CHLOROBENZENESULFONAMIDE

FB1.2: 13 residues within 4Å: Chain A: H.93, H.95, H.118, V.120, L.139, V.141, S.195, L.196, T.197, T.198, W.207 Ligands: ZN.1, GOL.3 3 PLIP interactions: 3 interactions with chain A Hydrophobic interactions: A:L.196 Hydrogen bonds: A:T.197, A:T.197

1 x GOL: GLYCEROL(Non-functional Binders)

GOL.3: 8 residues within 4Å: Chain A: N.61, H.63, A.64, N.66, Q.91, H.93, T.198 Ligands: FB1.2 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:N.61, A:N.66, A:Q.91

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Scott, A.D. et al., Thermodynamic Optimisation in Drug Discovery: A Case Study Using Carbonic Anhydrase Inhibitors. Chemmedchem (2009)

Release Date

2009-11-10

Peptides

CARBONIC ANHYDRASE 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

CARBONIC ANHYDRASE 2

Related Entries With Identical Sequence